Noroclox DC 500 mg suspensija ievadīšanai tesmenī liellopiem
Noroclox DC 500 mg suspensija ievadīšanai tesmenī liellopiem
Authorised
- Cloxacillin
Product identification
Medicine name:
Noroclox DC 500 mg suspensija ievadīšanai tesmenī liellopiem
Active substance:
- Cloxacillin
Target species:
-
Cattle (dry cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cloxacillin500.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dry cow)
-
Milk28dayPienam: 96 stundas pēc dzemdībām, ja cietstāves periods ir garāks par 28 dienām. Ja dzemdības notikušas ātrāk nekā 28 dienas pēc zāļu ievadīšanas, pienu cilvēku uzturā atļauts lietot pēc 28 dienām un 96 stundām.
-
Meat and offal28day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Available in:
-
Latvia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Manufacturing Limited
- Norbrook Laboratories Limited
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/NRP/96/0443
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 27/05/2025
